Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.
Stocks · News reference
JP Morgan analyst Thomas Palmer maintains Archer-Daniels-Midland (NYSE:ADM) with a Underweight and lowers the price target from $77 to $75.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.
SupplySide Global returns to Las Vegas October 26-30, 2026, featuring 1,600+ exhibiting companies, 135 hours of educational programming, and expanded networking opportunities. The event brings together ingredient suppliers, manufacturers, brands, and service providers from the supplement, food, and beverage industries for discovery and business acceleration.